FDA approves Marqibo for rare type of leukemia

Authosr(s):

On Aug. 9, the U.S. Food and Drug Administration (FDA) approved Marqibo (vincristine sulfate liposome injection) to treat adults with Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL). Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here